Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Hematology, Transfusion and Cell Therapy|September 13, 2024
Minor surgical procedures during immune tolerance induction in people with hemophilia A and inhibitors: results from the Brazilian Immune Tolerance (BrazIT) study cohortRicardo Mesquita Camelo, Maíse Moreira Dias, Suely Meireles Rezende, et al.Plos One|August 26, 2021
Predictors of the outcome of immune tolerance induction in patients with haemophilia A and inhibitors: The Brazilian Immune Tolerance (BrazIT) Study protocolRicardo Mesquita Camelo, Daniel Gonçalves Chaves, Luciana Werneck Zuccherato, et al.Journal of Arrhythmia|April 14, 2021
Third-degree atrioventricular block and pacemaker implantation in a man with severe hemophilia A: A case reportRicardo Mesquita Camelo, Bruna Pontes Duarte, Antônio Macedo do Nascimento, et al.Sao Paulo Medical Journal = Revista Paulista De Medicina|May 15, 2024
Emicizumab prophylaxis in people with hemophilia A and inhibitors: a systematic review and meta-analysisTiago Paiva Prudente, Ricardo Mesquita Camelo, Rafael Alves Guimarães, et al.Expert Review of Clinical Pharmacology|June 2, 2026
Prophylaxis for inherited factor X deficiency: a systematic reviewVitor José Poletto Ferreira, Alessandra Fatima da Costa, Renan Pedra Souza, et al.Thrombosis and Haemostasis|May 15, 2026
F8 genotype and immune tolerance induction outcome in people with hemophilia A and inhibitors: A systematic review and meta-analysisJúlia de Oliveira Barbosa, Isabella de Oliveira Barbosa, Renan Pedra Souza, et al.Expert Review of Hematology|December 9, 2023
Efficacy/effectiveness and safety of emicizumab prophylaxis of people with hemophilia A: a systematic review and meta-analysisRoberto Lúcio Muniz, Ricardo Mesquita Camelo, Maiara Silva Araújo, et al.Expert Review of Clinical Pharmacology|February 23, 2026
Factor-VIII mimetic bispecific antibodies for the treatment of hemophilia A: an updateVitória Eduarda Alves de Jesus, Douglas Lamounier de Almeida, Roberto Lúcio Muniz Júnior, et al.Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|November 29, 2023
Emicizumab prophylaxis for people with hemophilia A: Waste estimation and the Brazilian perspectiveRicardo Mesquita Camelo, Mariana Michel Barbosa, Luila Clicia Moura Henriques, et al.Expert Review of Hematology|February 19, 2026
Gene therapy in the treatment of hemophilia A: a systematic review and meta-analysisAna Clara Silva Mendes, Ricardo Mesquita Camelo, Luila Clicia Moura Henriques, et al.Pageof 3